Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 43.35% institutional investors, 2.26% insiders, and 54.39% retail investors. Vanguard group is the largest institutional shareholder, holding 4.37% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.94% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	43.35%	2.26%	54.39%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	788.59K	4.37%	$4.55M
Vivo capital	1.79M	1.13%	$11.78M
Millennium management	1.40M	0.88%	$9.21M
Octagon capital advisors lp	1.00M	0.63%	$6.58M
Nantahala capital management	939.20K	0.59%	$6.18M
Logos global management lp	473.56K	0.30%	$3.12M
Citadel advisors	236.84K	0.15%	$1.56M
Blackrock	51.84K	0.15%	$25.98K
Geode capital management	203.74K	0.13%	$1.34M
Susquehanna group, llp	199.22K	0.13%	$1.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vivo capital	1.79M	0.98%	$11.78M
Octagon capital advisors lp	1.00M	0.73%	$6.58M
Dauntless investment group	147.09K	0.64%	$967.83K
Nantahala capital management	939.20K	0.23%	$6.18M
Logos global management lp	473.56K	0.16%	$3.12M
Diametric capital, lp	80.36K	0.14%	$528.78K
Diadema partners lp	106.08K	0.12%	$698.03K
Persistent asset partners	26.83K	0.07%	$176.52K
Cantor fitzgerald, l. p.	75.00K	0.01%	$493.50K
Virtu financial	26.27K	0.01%	$173.00K

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	1.40M	0.00%	384.50K
Susquehanna group, llp	199.22K	0.00%	174.29K
Marshall wace, llp	154.94K	0.00%	154.94K
Dimensional fund advisors lp	143.05K	0.00%	143.05K
Morgan stanley	188.18K	0.00%	141.60K

Top Sellers

Holder	Shares	% Assets	Change
Walleye capital	-	-	-4.09M
Ra capital management	-	-	-2.63M
Silverarc capital management	-	-	-2.41M
Bvf inc/il	-	-	-2.20M
Alyeska investment group	-	-	-1.75M

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	154.94K	0.00%	154.94K	$1.02M
Dimensional fund advisors lp	143.05K	0.00%	143.05K	$940.17K
Diadema partners lp	106.08K	0.12%	106.08K	$698.03K
Vanguard fiduciary trust	101.07K	0.00%	101.07K	$665.07K
Diametric capital, lp	80.36K	0.14%	80.36K	$528.78K

Sold Out

Holder	Change
Jpmorgan chase	-184.00
Wells fargo & company/mn	-196.00
Soa wealth advisors, llc.	-1.00K
Tower research capital llc (trc)	-1.92K
Redwood wealth management group	-3.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	90	57.89%	11,667,872	17.78%	43	2.52%	61	96.77%	10	-
Mar 31, 2026	14	-62.16%	1,132,417	-86.10%	-	0.04%	7	-53.33%	4	-42.86%
Dec 31, 2025	29	-3.33%	5,630,293	-10.43%	31	2.57%	11	-52.17%	5	400.00%
Sep 30, 2025	30	66.67%	6,285,927	22.20%	34	1.99%	24	380.00%	1	-92.31%
Jun 30, 2025	18	-37.93%	5,144,082	-91.42%	41	1.59%	5	-64.29%	13	62.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	805.72K	2.94%	194.70K
Vanguard Morn Total Stk Mkt Idx Investor	805.72K	2.94%	194.70K
Vanguard MStar Total Stk Mkt Idx Invest	805.72K	2.89%	-
iShares Russell 2000 ETF	602.78K	2.20%	-10.75K
Vanguard Institutional Extnd Mkt Idx Tr	240.02K	0.86%	-
iShares Russell 2000 Growth ETF	196.84K	0.72%	-1.81K
Russell 2000 Equity Index Fund B	157.64K	0.58%	157.64K
Russell 2000 Index Non-Lendable Fund	157.64K	0.58%	157.64K
PPF Helix Biotechnology I USD	146.00K	0.53%	146.00K
State St Russell Sm/Mid Cp® Indx SL Cl I	143.40K	0.51%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 43.35%, followed by 2.26% insiders and 54.39% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 379.61%, which Unicycive Therapeutics falls below.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Vanguard group (788.59K shares, 4.37%), Vivo capital (1.79M shares, 1.13%), and Millennium management (1.4M shares, 0.88%). Together, they hold 6.37% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.98% of its assets in 1.79M Unicycive Therapeutics shares, valued at 11.78M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 2.94% of its total shares outstanding invested in 805.72K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools